维普期刊资源整合服务平台（V6.5）

73篇 您的检索式：作者名="Johnson BF"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Vascular endothelial growth factor and immunosuppression in cancer: current knowledge and po?tential for new therapy显示文摘	Johnson BF Clay TM Hobeika AC	2007	Expert Opin Bioi Ther2007，7，4：	1
2	Risk factors for postherpetic neuralgia in patients with herpes zoster 显示文摘	Jung BF Johnson RW Griffin DR	2004	Neurology2004，62，9：	1
3	Risk factors for postherpatic neuralgia in patients with herpes roster 显示文摘	Jung BF Johnson RW Grifin DR	2004	Neurology2004，62，：	1
4	Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin显示文摘	Gage BF Eby C Johnson JA	2008	Clin Pharmacol Ther2008，84，3：	1
5	EvoIution of Maryland trauma:fromdeath lab to statewide system显示文摘	Hellor DL Johnson BF Doyie K	2010	J Tmuma Nurs2010，17，3：	1
6	Urinary thromboxane and 6-keto-prostaglandin F1alpha are early markers of acute rejection in experimental pancreas transplantation显示文摘	Johnson BF Wiley KN Greaves M	1994	Transplantation1994，58，1：	1
7	Risk factors forpostherpetic neuralgia in patients with herpes zoster 显示文摘	Jung BF Johnson RW Griffn DRJ	2004	Neurology2004，62，9：	1
8	Sexual co-flocculation and asexual self-flocculation of heterothallic fission yeast cells (Schizosaccharomyces pombe)显示文摘	Johnson BF Walker T Miyata M	1987	Canadian Journal of Microbiology1987，33，8：	1
9	Use of pharmacogenetic and clinical factors to predict the therapeuticdose of warfarin显示文摘	GAGE BF EBY C JOHNSON JA	2008	Clin Pharmacol Ther2008，84，3：	1
10	Use of phar- maeogenetic and clinical faetors to predict the ther- apeutic dose of warfarin显示文摘	Gage BF Eby C Johnson JA	2008	Clin Pharmacol Ther2008，84，3：	1
11	Genetic warfa-rin dosing;tables versus algorithms显示文摘	Finkelman BS Gage BF Johnson JA	2011	J Am Coll Cardi-ol2011，57，5：	1
12	Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin 显示文摘	Gage BF Eby C Johnson JA	2008	Clin Pharmacol Ther2008，84，3：	1
13	Farr MJ(1999)Randomized prospective comparison of laparoscopic and open peritoneal dialysis catheter insertion显示文摘	Wright MJ Bel' eed K Johnson BF	1999	Perit Dial Int1999，19，：	1
14	Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin显示文摘	Gage BF Eby C Johnson JA	2008	Clin Pharmacol Ther2008，84，3：	1
15	Role of osteo-pathic manipulative in altering pain biomarkers: a pilot study 显示文摘	Degenhardt BF Darmani NA Johnson JC	2007	J Am Osteopath Assoc2007，107，9：	1
16	Risk factors for postherpetic neuralgiain patients with herpes zoster显示文摘	Jung BF Johnson RW Griffin DR	2004	NeuroLogy2004，62，9：	1
17	Water relations in winter wheat as drought resistance indicator显示文摘	Schonfeld MA Johnson RC Carver BF etal	1988	Crop Science1988，28，：	1
18	G eneticw arfarin dosing tables versus algorithm s 显示文摘	F inkelm an BS Gage BF Johnson JA e t a l	2011	J Am CollCardiol2011，57，5：	1
19	Risk factors for postherpetic neuralgia in patients with herpes zoster显示文摘	Jung BF Johnson RW Griffin DR		0，，09：	1
20	The effect of source animal age upon the in vivo remodeling characteristics of an extracellular matrix scaffold显示文摘	Sicari BM Johnson SA Siu BF	2012	Biomaterials2012，33，22：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示